Hematology-Oncology Associates of Rockland
New City, New York, United States
Hematologist in Nyack, New York
160 N Midland Ave, Nyack, NY 10960
About Hematology-Oncology Associates of Rockland
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Telik
2
Point Therapeutics
1
Taiho Oncology, Inc.
1
Weill Medical College of Cornell University
1
Clinical Trials at Hematology-Oncology Associates of Rockland
During the past decade, Hematology-Oncology Associates of Rockland conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
2004-12-01
2008-07-01
Completed
244
Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
Terminated
60
A Safety and Efficacy Study in Patients With Gastric Cancer
2005-05-01
2008-04-01
Completed
1,053
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology-Oncology Associates of Rockland"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hematology-Oncology Associates of Rockland
According to Clinical.Site data, the most researched conditions in "Hematology-Oncology Associates of Rockland" are
"Ovarian Neoplasms" (2 trials), "Adenocarcinoma" (1 trials), "Gastric Cancer" (1 trials), "Neoplasm Metastasis" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Hematology-Oncology Associates of Rockland" in a lesser frequency.
Clinical Trials Intervention Types at Hematology-Oncology Associates of Rockland
Most popular intervention types in "Hematology-Oncology Associates of Rockland" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "5-FU/cisplatin" (1 trials), "Dasatinib" (1 trials), "Doxorubicin HCl Liposome Injection" (1 trials), "S-1/Cisplatin" (1 trials) and "TLK286 HCl for injection" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hematology-Oncology Associates of Rockland
The vast majority of trials in "Hematology-Oncology Associates of Rockland" are
3 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Hematology-Oncology Associates of Rockland
Currently, there are NaN active trials in "Hematology-Oncology Associates of Rockland".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hematology-Oncology Associates of Rockland,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hematology-Oncology Associates of Rockland, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".